Clinical trials recruiting for Papillomavirus Infection
Fewer than 3 recruiting trials found.
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Docetaxel (Taxotere) | 1 |
| Human papillomavirus 9-valent vaccine, recombinant | 1 |
| Irinotecan (Camptosar) | 1 |
| STAR0602 | 1 |
| human papillomavirus vaccine, recombinant | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Florida | 1 |
| Kansas | 1 |
| Louisiana | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| Ohio | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Washington | 1 |
| Wisconsin | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
Related conditions
Trials recruiting for Papillomavirus Infection often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Papillomavirus Infection trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.